(R)-(1,4-Dioxan-2-yl)methanol hydrate, 95.0%, 100mg

1-benzyl-3-(chloromethyl)piperidine hydrochloride, 95.0%, 5g

Fmoc-(S)-3-Amino-3-(4-chlorophenyl)propionic acid, 95.0%, 1g

4-chloro-5-ethyl-2-methylpyrimidine, 95.0%, 5g

(2-(Difluoromethoxy)pyridin-3-yl)methanol, 95%, 100mg

1,2-Diphenylethylamine>97.0%(GC)(T)5g

(E)-(2-((HYDROXYIMINO)METHYL)PHENYL)BORONIC ACID, 95%, 100mg

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

cyclobutyl 2-(4-thiomethylphenyl)ethyl ketone, 97.0%, 1g

3-(Bromomethyl)oxetane, 95.0%, 5g

Volumetric flasks class A Brown glass, 50 ml, 14/23, 2 unit(s), 2 Piece(s)

2-(4-CHLOROPHENYL)-N-METHYLACETAMIDE, 95.0%, 5g

(E)-3-(3-Bromofuran-2-yl)acrylic acid, 500mg